Hopkins C, Rimmer J, Lund V J
Rhinology. 2015 Mar;53(1):10-7. doi: 10.4193/Rhino13.217.
Patients with chronic rhinosinusitis refractory to medical management undergo elective surgery. The time from initial diagnosis to surgery varies considerably. The impact of this delay on surgical success has never previously been evaluated.
First-time patients within the National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis were grouped based on time to surgery: 1) Early cohort: %lt; 12 months; 2) Mid cohort: 12-60 months; and 3) Late cohort: > 60 months. Co-morbidities and preoperative CT scores were analysed for all patients.
The 22-item Sino-Nasal Outcome Test scores (SNOT-22) were collected at 0, 3, 12 and 60-months. Absolute and relative SNOT-22 changes from baseline were evaluated.
Asthma and allergies were significantly more prevalent in the Late versus the Early and Mid-cohorts. In addition, patients in the Late cohort had greater symptom burden on the SNOT-22 and more extensive preoperative radiographic disease as determined by Lund-Mackay (LM) scores. SNOT-22 scores demonstrated greater percentage improvements in the Early versus the Mid- and Late cohorts, at all time points after surgery. At 12 and 60 months after surgery, significantly more patients in the Early group achieved a clinically important change in SNOT-22 scores compared with the other groups. These differences were maintained when cohorts were matched for preoperative co-morbidities.
Patients with asthma and/or allergies are more likely to experience delayed surgical intervention versus other patients. Overall, patients with delayed surgery reported less improvement in SNOT-22 scores than patients treated at earlier time points, regardless of co-morbid status. Delaying surgical intervention may worsen long term clinical outcomes.
药物治疗无效的慢性鼻窦炎患者需接受择期手术。从初次诊断到手术的时间差异很大。此前从未评估过这种延迟对手术成功率的影响。
在全国鼻息肉和慢性鼻窦炎手术比较审计中,首次就诊的患者根据手术时间分组:1)早期队列:<12个月;2)中期队列:12 - 60个月;3)晚期队列:>60个月。分析所有患者的合并症和术前CT评分。
在0、3、12和60个月时收集22项鼻鼻窦结局测试评分(SNOT - 22)。评估SNOT - 22相对于基线的绝对和相对变化。
晚期队列中哮喘和过敏的患病率明显高于早期和中期队列。此外,根据Lund - Mackay(LM)评分,晚期队列患者的SNOT - 22症状负担更重,术前影像学疾病范围更广。在术后所有时间点,早期队列的SNOT - 22评分改善百分比均高于中期和晚期队列。术后12个月和60个月时,与其他组相比,早期组有更多患者的SNOT - 22评分实现了具有临床意义的变化。当队列根据术前合并症进行匹配时,这些差异仍然存在。
与其他患者相比,患有哮喘和/或过敏的患者更有可能经历手术干预延迟。总体而言,手术延迟的患者SNOT - 22评分的改善程度低于早期接受治疗的患者,无论合并症状态如何。延迟手术干预可能会使长期临床结局恶化。